Cargando…
Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease 2019: A living review and meta-analysis
Inhaled corticosteroids are known to be relatively safe for long-term use in inflammatory respiratory diseases and it has been repurposed as one of the potential therapies for outpatients with coronavirus disease 2019 (COVID-19). However, inhaled corticosteroids have not been accepted for COVID-19 a...
Autores principales: | Yu, Su-Yeon, Choi, Miyoung, Ryoo, Seungeun, Cheong, Chelim, Huh, Kyungmin, Yoon, Young Kyung, Jeong, Su Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684004/ https://www.ncbi.nlm.nih.gov/pubmed/38015868 http://dx.doi.org/10.1371/journal.pone.0294872 |
Ejemplares similares
-
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
por: Yu, Su-Yeon, et al.
Publicado: (2022) -
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Ryoo, Seungeun, et al.
Publicado: (2023) -
531. Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease-2019: an updated systematic review and meta-analysis
por: Jeong, Su Jin
Publicado: (2023) -
Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on
por: Lipworth, Brian, et al.
Publicado: (2020) -
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)